Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Cancer Res. 2010 Sep 28;70(19):7543–7552. doi: 10.1158/0008-5472.CAN-09-4582

Table 2.

Urinary nicotine metabolite profile in 104 smokers.

% of Total-NIC-Eqa
Creatinine-adjusted levels (nmol/mg creatinine)b
Mean ± S.D. (95% CI)c Range Mean ± S.D. (95% CI) Range
3HC 33.6 ± 8.7 (32.0–35.4) 5.9–53.4 42.4 ± 25.2 (37.6–47.3) 0.78–145
3HC-Gluc 16.7 ± 7.8 (15.1–18.2) 3.3–43.6 21.8 ± 18.5 (18.2–25.3) 0.44–124
Cotinine 11.0 ± 6.6 (9.8–12.2) 2.9–32.0 14.2 ± 11.9 (11.9–16.5) 0.97–70
Nicotine 10.6 ± 7.3 (9.2–12.0) 0.58–31.7 12.9 ± 11.5 (11.0–15.2) 0.42–64
4HPBA 8.9 ± 3.7 (8.1–9.6) 3.1–32.3 10.6 ± 6.0 (9.4–11.8) 0.95–37
Cotinine-Gluc 7.3 ± 3.4 (6.6–8.0) 0–18.8 8.7 ± 5.3 (7.6–9.7) 0.00–26
Nicotine-N′-Oxide 4.8 ± 2.5 (4.3–5.3) 1.4–13.4 5.6 ± 3.2 (4.9–6.2) 0.36–18
Nicotine-Gluc 4.3 ± 3.4 (3.6–4.9) 0–19.5 5.0 ± 4.6 (4.2–5.8) 0.00–31
Cotinine-N-Oxide 2.8 ± 0.77 (2.7–3.0) 1.2–5.0 3.4 ± 1.6 (7.6–9.7) 0.58–8.1
a

Ratio of individual nicotine metabolite (μM) measured as a percentage of total urinary nicotine metabolites [Total-NIC-Eq (μM)].

b

Ratio of individual nicotine metabolite (μM) measured as a percentage of urinary creatinine (mg).

c

S.D. = standard deviation; CI = confidence interval.